Dr. F. Arslan

Top-cited publications

1354 times cited (±112/year) Source: Scopus

Stem cell research, Volume 4, Issue 3, 4 1 2010, Pages 214-222 Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP, Lim SK. Abstract


676 times cited (±75/year) Source: Scopus

Stem cell research, Volume 10, Issue 3, 14 2 2013, Pages 301-312 Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor EN, Timmers L, van Rijen HV, Doevendans PA, Pasterkamp G, Lim SK, de Kleijn DP. Abstract


422 times cited (±30/year) Source: Scopus

Stem cell research, Volume 1, Issue 2, 1 1 2007, Pages 129-137 Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, El Oakley RM, Choo A, Lee CN, Pasterkamp G, de Kleijn DP. Abstract


Most recent publications

17 Dec 2021

International journal of cardiology, 17 3 2021 Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation. D'Ancona G, Arslan F, Safak E, Weber D, Al Ammareen R, Ince H. Abstract


30 Oct 2021

International journal of molecular sciences, Volume 22, Issue 21, 30 5 2021 Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice. Kessler EL, Wang JW, Kok B, Brans MA, Nederlof A, van Stuijvenberg L, Huang C, Vink A, Arslan F, Efimov IR, Lam CSP, Vos MA, de Kleijn DPV, Fontes MSC, van Veen TAB. Abstract


15 Oct 2021

Clinical research in cardiology : official journal of the German Cardiac Society, 15 3 2021 Left atrial appendage closure with the watchman device reduces atrial fibrillation management costs. D Ancona G, Safak E, Weber D, Arslan F, Kische S, Darius H, Behrens S, Zohlenhöfer-Momm D, Ortak J, Kugler J, Ince H. Abstract